Evidence map›Paper›PMID 40687624›Full record

ArticleAdvances in pharmacological and pharmaceutical sciences2025

In Vitro Cytotoxic and Molecular Docking Studies of the Network Pharmacology Approach From Bioactive Compounds of

Kasta Gurning, Gian Primahana, Endang Astuti, Winarto Haryadi

Abstract read
In one paragraph

Article in Advances in pharmacological and pharmaceutical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kasta GurningDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.ORCID https://orcid.org/0000-0002-0676-0030
Gian PrimahanaResearch Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), South Tangerang 15314, Indonesia.ORCID https://orcid.org/0000-0001-8176-3859
Endang AstutiDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.ORCID https://orcid.org/0000-0002-6401-2719
Winarto HaryadiDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.ORCID https://orcid.org/0000-0001-7970-1528

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer and breast cancer are two types of cancer that cause and contribute to the highest mortality rate in the world. The development of anticancer agents that have high efficacy and relatively low side effects continues to be developed and is the focus of research, and one of the raw materials that can be explored is active compounds sourced from natural materials, one of which is plants. This study aims to isolate active compounds from bangun-bangun (

Indexed as

breast cancerColeus amboinicuslung cancerMMP-2MTT

Identifiers

PMID40687624
PMCPMC12274097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.